Promega Corporation

In Vitro Compound Profiling in 384- and 1536-Well Formats Using Bioluminescent ADME...

In Vitro Compound Profiling in 384- and 1536-Well Formats Using Bioluminescent ADME Assays to Understand In Vivo Biology
  • Share
  • Print
  • Email
  • Article

Abstract

This article describes metabolic profiling applications in which compounds are assayed against several different drug metabolizing enzymes on the same assay plate. We obtain potency data for cytochrome P450 and monoamine oxidase A using this parallel approach and dose-response testing of compounds using both 384-well and 1536-well plate configurations.

Cell Notes 16, 4–8.

Tracy Worzella1, James Cali1, Neal Cosby1, Jean Shieh2, Aoife Gallagher3, Kim Titus4, Gerlinde Zerza-Schnitzhofer5

1Promega Corporation, 2Labcyte Corporation, 3Deerac Fluidics, 4Corning Inc. 5Tecan AG Corporation
2006
  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.